Evidence map›Paper›PMID 36853422›Full record

ArticleEJNMMI research2023

Engineering a modular

Nadia Benabdallah, Hanwen Zhang, Ryan Unnerstall, Amanda Fears, Lucy Summer, Michael Fassbender, Buck E Rodgers, Diane Abou, Valery Radchenko, Daniel L J Thorek

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Production of high purityEJNMMI radiopharmacy and chemistry · 2024
    Article
  2. Article
  3. Article
  4. Titanium-45 (Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Nadia BenabdallahWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA.
Hanwen ZhangWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA. hanwen.zhang@wustl.edu.
Ryan UnnerstallWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA.
Amanda FearsWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA.
Lucy SummerWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA.
Michael FassbenderChemistry Division, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM, 87545, USA.
Buck E RodgersWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA.
Diane AbouWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA.
Valery RadchenkoLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.
Daniel L J ThorekWashington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, St. Louis, MO, 63110, USA. thorekd@wustl.edu.
Mallinckrodt (United States) · USWashington University in St. Louis · USLos Alamos National Laboratory · USTRIUMF · CA

Funding

The Radium-223 Combination Therapy Space; Improving Response and Clarifying ToxicitiesR01CA240711 · NCI · WASHINGTON UNIVERSITY · PI MICHALSKI, JEFF M., THOREK, DANIEL LYNDON JAFFE · 2020 to 2024
$2.2M
Opening the Therapeutic Window for PSMA-Targeted Molecular RadiotherapyR01CA229893 · NCI · WASHINGTON UNIVERSITY · PI THOREK, DANIEL LYNDON JAFFE · 2019 to 2024
$1.9M
Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate CancerR01CA201035 · NCI · WASHINGTON UNIVERSITY · PI THOREK, DANIEL LYNDON JAFFE · 2017 to 2020
$1.4M
Children's Discovery Institute MC-II-2021-961National Research Council of Canada TRIUMPHNCI NIH HHS R01 CA201035NCI NIH HHS R01CA201035NCI NIH HHS R01 CA229893NCI NIH HHS R01CA229893NCI NIH HHS R01CA240711
6 · The paper itself

Abstract

background

methods

results

conclusionsA clinical-scale

Indexed as

Isotope generatorPharmacokineticsPositron emission tomographyScandium-44

Identifiers

PMID36853422
PMCPMC9975127
OpenAlexW4322616654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.